The FDA has granted approval to subcutaneous Keytruda for use in adults and pediatric patients with a solid tumor.
Subcutaneous daratumumab is well tolerated, but ongoing immune monitoring is key to managing infection risk in patients with ...
SurvivorNet on MSN
FDA Approves New Subcutaneous (Under-the-Skin) Option for Keytruda: What It Means for Cancer Patients
The U.S. Food and Drug Administration (FDA) has approved the subcutaneous form of Keytruda for a new 'Under-the-Skin' Option ...
Merck's Keytruda Qlex offers a groundbreaking subcutaneous cancer treatment, enhancing patient convenience with faster ...
The US Food and Drug Administration (FDA) has approved the biologics license application for a subcutaneous formulation of lecanemab (Leqembi Iqlik) for weekly maintenance dosing to treat Alzheimer’s ...
The FDA has approved a subcutaneous induction regimen of guselkumab for the treatment of adults with moderately to severely ...
The U.S. Food and Drug Administration has approved Leqembi Iqlik, a subcutaneous version of lecanemab, for weekly maintenance after the 18-month intravenous (IV) phase. Leqembi Iqlik is a subcutaneous ...
The Chosun Ilbo on MSN
Keytruda Subcutaneous Formulation Receives FDA Approval
The first immune checkpoint inhibitor that can be administered via a subcutaneous injection in just 1 to 2 minutes has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback